TAGGED STORIES
Anthropic launched the roadshow for its proposed initial public offering and set a price range of $70 to $78 a share, with most of the shares coming from the company and some from existing stockholders.
METR said Anthropic redacted a majority of the evidence it considered most informative in an October 2026 assessment of AI R&D acceleration, limiting how much of its reasoning it could describe publicly.
Anthropic filed for a proposed IPO while leaving share count and price range undetermined, making its market story bigger than its disclosed terms.
Anthropic said it expanded its agreement with the General Services Administration to offer a 40% discount on Claude products to federal, state, local, tribal and territorial governments.
Anthropic filed a registration statement with the SEC for a proposed initial public offering of its Class A common stock, and said the share count and price range have not yet been set.
UK government response to the AI regulation consultation emphasizes sector-based rules, a £100 million investment, and OpenAI and Anthropic's public support for the approach.
Barclays is extending Claude across its operations to speed software development, modernize legacy systems and improve customer and client outcomes, with adoption targets set through 2027.
A divided D.C. Circuit rejected Anthropic’s challenge to Claude’s exclusion from the military supply chain, with a dissent disputing the statute’s reach.
Anthropic reports Claude's agents flagged a CRISPR-like enzyme system with no known function, described as ART.
A straight news report on Anthropic's partnership with Accenture to embed independent evaluators within its AI development process, and related safety and governance considerations discussed by company leaders and researchers.